Alan Walshe Thanks PPTA on Behalf of Plasma Donors And Patients Who Rely on PDMPs
Alan Walshe, Senior Vice President, Head of Global Commercial Strategy for Plasma Derived Therapies at Takeda, reposted from Anita Brikman on LinkedIn:
”This year’s Plasma Protein Forum, taking place in Washington DC, is tackling the most urgent issues facing Plasma-Derived Medicinal Products (PDMPs) including growing patient need, plasma donor health and the vital importance of partnering with regulators and other stakeholders.
Thank you Plasma Protein Therapeutics Association (PPTA) for your important work on behalf of plasma donors and patients who rely on PDMPs.”
Quoting Anita Brikman‘s post:
”Day one of the Plasma Protein Forum set a powerful tone for collaboration, innovation, and impact across the plasma community.
Plasma Protein Therapeutics Association (PPTA) Global Executive Board Chair Giles Platford began the day by reminding attendees of the importance of science-driven progress and global partnership.
Dr. Namandje Bumpus continued that discussion by delivering a collaborative keynote on regulatory excellence.
Sessions then moved to thought-provoking examinations on trade, donor health, state policy, and innovation.
Each session underscored the industry’s shared commitment to donors and patients.
A special thank you to all speakers, moderators, and sponsors who made today’s sessions and networking moments so engaging.
I am excited to see what tomorrow will bring at PPF2025.”

More from PPF2025 featured in Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis